Previous studies demonstrated that eNO measured from the upper airway was significantly increased in subjects with OSA and that was linked to overexpression of inducible NOS (iNOS) [4, 5, 7, 8], which was partially reversible after CPAP treatment [8–10]. The gene discussed is NOS2; the disease is obstructive sleep apnea syndrome.